Frontier Lifeline Hospital Pioneering a Breakthrough
*Frontier Lifeline Hospital Pioneering a Breakthrough in Pulmonary Hypert ension Treatment*
Chennai, The team at frontier lifeline hospital successfully performed a land mark procedure, marking one of the v ery few pulmonary artery denervation cases in India.
A 55-year-old woman presented with s evere pulmonary hypertension and ri ght heart failure, showing no significa nt improvement despite multiple medi cations aimed at decreasing her pulmo nary pressure. Her mean pulmonary a rtery pressure was critically high at 85 Hg, causing her clinical status to conti nually decline. After an extensive dia gnostic evaluation, she was diagnosed with idiopathic pulmonary hypertensi on, a condition lacking effective treat ment options.
The teams frontier life line hospital o pted for pulmonary artery denervatio n, a novel therapy at the forefront of medical research. This procedure hol d s promise as an innovative solution for reducing pulmonary pressure. The breakthrough treatment led to a signi ficant reduction in the patient’s pulmo nary artery pressure by 15mmHg, signi fying hope for significant long-term im provements.
Dr. Sam Jacob, head of electrophysiol ogy program commented that “This pr ocedure represents a potential turning point for patients suffering from pulm onary artery hypertension, a condition where we’ve previously had limited tr eatment options. We are optimistic ab out the possibilities this therapy prese nts in changing lives.”
The pulmonary artery denervation the rapy is currently within the clinical tri ial phase yet presents a beacon of hope for patients with pulmonary arterial h ypertension (PAH), as it could revoluti onize existing treatment protocols.
Frontier Lifeline Hospital is dedicated to staying at the forefront of medical a dvancements and providing cutting-ed ge treatments to cardiac patients. This successful procedure underscores the ir commitment to patient care and me dical innovation, aligning with the mis sion of Dr KM Cherian Heart Foundati on to enhance cardiac treatments and outcomes .
